AMIX Autonomix Medical, Inc. - Common Stock
$0,28
Cena · Maj 20, 2026
Dane fundamentalne na dzień Lut 11, 2026
Zakres 52 tyg.
$0–$3
3% of range
Ocena Analityków
BUY
8 analysts
Cena Docelowa
$2
+627% upside
P/E (TTM)
—
ROE
—
Marża Zysku Netto
—
AMIX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.28
Kapitalizacja Rynkowa
—
P/E (TTM)
—
EPS (TTM)
—
Przychody (TTM)
$0
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $3
AMIX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$0
2023-03-31
→
2025-03-31
EPS
—
Wolny przepływ pieniężny
—
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
AMIX
Mediana porównawcza
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
AMIX
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
AMIX
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
AMIX
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
AMIX
Mediana porównawcza
AMIX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
8 analityków
- Mocne kupno 3 37,5%
- Kup 4 50,0%
- Trzymaj 1 12,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-05-17
Niski
$2.00
Wysoki
$2.00
Średni cel
$2.00
+627,3%
Średnia cel
$2.00
+627,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.16%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 grudnia 2025 | $-0.36 | $-0.60 | 0.24% |
| 30 września 2025 | $-1.38 | $-1.13 | -0.25% |
| 30 czerwca 2025 | $-1.07 | $-1.00 | -0.07% |
| 31 marca 2025 | $-1.81 | $-1.26 | -0.55% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AMIX | — | — | — | — | — | — |
| FEED | $3M | -0.1 | -0.20% | -712.3% | -49.2% | 6.0% |
| AEMD | $58M | -3.4 | — | — | -283.1% | — |
| GCTK | $4M | 0.1 | — | — | -399.4% | — |
| NUWE | $3M | -0.1 | -5.4% | -211.9% | 553.1% | 62.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | |
| R&D Expense | $5M | $2M | $745.0K | |
| SG&A Expense | $7M | $5M | $1M | |
| Operating Expenses | $12M | $12M | $2M | |
| Operating Income | $-12M | $-12M | $-2M | |
| Interest Income | $354.0K | $127.0K | $0 | |
| Other Non-op | $178.0K | $-3M | $0 | |
| Pretax Income | $-11M | $-15M | $-2M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-11M | $-15M | $-2M | |
| EPS (Basic) | $-6.46 | $-14.82 | $-0.17 | |
| Shares (Basic) | 1,766,425 | 1,040,720 | 12,023,112 |
Bilans 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $9M | $9M | $865.0K | |
| Other Current Assets | $473.0K | $783.0K | $0 | |
| Current Assets | $10M | $9M | $865.0K | |
| PP&E (Net) | $21.0K | $16.0K | $0 | |
| Total Assets | $10M | $9M | $865.0K | |
| Accounts Payable | $676.0K | $492.0K | $173.0K | |
| Accrued Liabilities | $1M | $285.0K | $48.0K | |
| Short-term Debt | · | $0 | · | |
| Current Liabilities | $2M | $777.0K | $221.0K | |
| Other Non-current Liabilities | · | · | $0 | |
| Total Liabilities | $2M | $2M | $221.0K | |
| Long-term Debt | · | · | $0 | |
| Common Stock | $2.0K | $1.0K | $12.0K | |
| Paid-in Capital | $58M | $47M | $24M | |
| Retained Earnings | $-50M | $-39M | $-24M | |
| Stockholders' Equity | $8M | $8M | $644.0K | |
| Liabilities + Equity | $10M | $9M | $865.0K | |
| Shares Outstanding | 2,497,033 | 942,575 | 12,336,571 |
Przepływy pieniężne 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | · | $81.0K | $0 | |
| Stock-based Comp | · | $618.0K | $0 | |
| Operating Cash Flow | $-8M | $-7M | $-2M | |
| CapEx | · | $19.0K | $0 | |
| Investing Cash Flow | · | $-19.0K | $0 | |
| Stock Issued | · | $3M | $675.0K | |
| Financing Cash Flow | · | $14M | $675.0K | |
| Net Change in Cash | · | $8M | $-1M |
Wycena (TTM) 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | |
| Net Income TTM | $-11M | $-15M | · | |
| P / Tangible Book | 0.5 | 149.2 | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $2M | $2M | $2M | $2M | $1M | $1M | $954.0K | $699.0K | $687.0K | $471.0K | $368.0K | |
| SG&A Expense | $2M | $5M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $793.0K | $503.0K | |
| Operating Expenses | $3M | $8M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $6M | $871.0K | |
| Operating Income | $-3M | $-8M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-6M | $-871.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Interest Income | $82.0K | $83.0K | $84.0K | $107.0K | $80.0K | $72.0K | $95.0K | $79.0K | $23.0K | $19.0K | $6.0K | |
| Other Non-op | $82.0K | $83.0K | $84.0K | $60.0K | $35.0K | $29.0K | $54.0K | $-3M | $-189.0K | $-220.0K | $6.0K | |
| Pretax Income | $-3M | $-7M | $-3M | $-3M | $-3M | $-3M | $-3M | $-5M | $-3M | $-6M | $-865.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-7M | $-3M | $-11M | $-3M | $-3M | $-3M | $-15M | $-3M | $-6M | $-865.0K | |
| EPS (Basic) | $-0.36 | $-1.38 | $-1.07 | $-0.53 | $-1.46 | $-2.27 | $-2.20 | $-2.90 | $-3.07 | $-8.78 | $-0.07 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | $-0.23 | · | · | |
| Shares (Basic) | 8,955,809 | 5,411,709 | 3,105,156 | -2,545,213 | 1,851,910 | 1,234,305 | 1,225,423 | -13,545,760 | 1,014,036 | 687,840 | 12,884,604 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | 13,799,170 | · | · | |
| EBITDA | $-3M | $-8M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | · | · |
Bilans 19
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $7M | $9M | $9M | $12M | $5M | $7M | $9M | $1M | · | · | |
| Other Current Assets | $257.0K | $416.0K | $389.0K | $473.0K | $109.0K | $199.0K | $325.0K | $783.0K | $467.0K | · | · | |
| Current Assets | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| PP&E (Net) | $20.0K | $16.0K | $19.0K | $21.0K | $20.0K | $17.0K | $19.0K | $16.0K | $14.0K | · | · | |
| Total Assets | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Accounts Payable | $714.0K | $842.0K | $815.0K | $676.0K | $232.0K | $574.0K | $287.0K | $492.0K | $663.0K | · | · | |
| Accrued Liabilities | $936.0K | $645.0K | $1M | $1M | $881.0K | $683.0K | $476.0K | $285.0K | $310.0K | · | · | |
| Short-term Debt | · | · | · | · | $1M | · | · | · | · | · | · | |
| Current Liabilities | $2M | $1M | $2M | $2M | $2M | $1M | $763.0K | $777.0K | $973.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $5M | · | · | |
| Total Liabilities | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $7M | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | $1M | · | · | |
| Total Debt | · | · | · | · | $1M | · | · | · | · | · | · | |
| Common Stock | $11.0K | $6.0K | $4.0K | $2.0K | $2.0K | $1.0K | $19.0K | $1.0K | $14.0K | · | · | |
| Paid-in Capital | $73M | $68M | $61M | $58M | $57M | $48M | $47M | $47M | $28M | · | · | |
| Retained Earnings | $-64M | $-61M | $-54M | $-50M | $-47M | $-44M | $-42M | $-39M | $-34M | · | · | |
| Stockholders' Equity | $9M | $6M | $7M | $8M | $10M | $3M | $5M | $8M | $-6M | · | · | |
| Liabilities + Equity | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Shares Outstanding | 11,409,344 | 6,194,147 | 4,022,625 | 2,497,033 | 2,462,983 | 1,152,120 | 19,242,081 | 942,575 | 14,430,221 | · | · |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.0K | $2.0K | $3.0K | $183.0K | $47.0K | $45.0K | $43.0K | $81.0K | $35.0K | $0 | $0 | |
| Stock-based Comp | $2.0K | $138.0K | $388.0K | $2M | $418.0K | $445.0K | $360.0K | $618.0K | $212.0K | $151.0K | $0 | |
| Other Non-cash | · | · | $342.0K | · | · | · | $444.0K | · | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-8M | $-2M | $-2M | $-2M | $-7M | $-3M | $-1M | $-661.0K | |
| CapEx | $7.0K | $0 | $0 | $14.0K | $5.0K | $0 | $5.0K | $19.0K | $16.0K | $0 | $0 | |
| Investing Cash Flow | $-7.0K | $0 | $0 | $-14.0K | $-5.0K | $0 | $-5.0K | $-19.0K | $-16.0K | $0 | $0 | |
| Stock Issued | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $5M | $3M | $2M | $9M | $9M | $0 | $0 | $14M | $2M | $350.0K | $3M | |
| Net Change in Cash | $2M | $-1M | $-547.0K | $528.0K | $7M | $-2M | $-2M | $8M | $-927.0K | $-794.0K | $2M | |
| Free Cash Flow | · | · | $-3M | · | · | · | $-2M | · | · | · | · |
Rentowność 3
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -29.4% | -112.0% | -41.5% | · | -39.4% | -104.5% | -76.1% | · | -344.2% | · | · | |
| ROE | -35.7% | -157.3% | -54.2% | · | -131.9% | -185.4% | -102.1% | · | 111.3% | · | · | |
| ROIC | -39.1% | -116.9% | -48.6% | · | -25.3% | -93.7% | -52.0% | · | 52.3% | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 5.3 | 4.6 | · | 5.3 | 4.3 | 9.3 | · | 1.7 | · | · | |
| Quick Ratio | 6.0 | 5.0 | 4.4 | · | 5.3 | 4.1 | 8.8 | · | 1.3 | · | · | |
| Debt / Equity | · | · | · | · | 0.1 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -88.6 | · | · |
Efektywność 1
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Wycena (TTM) 9
| Wskaźnik | Trend | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | |
| Net Income TTM | $-25M | $-25M | $-20M | · | $-24M | $-24M | $-27M | · | $-11M | · | · | |
| Market Cap | $6M | $7M | $6M | · | $9M | $14M | $369M | · | · | · | · | |
| Enterprise Value | · | · | · | · | $-1M | · | · | · | · | · | · | |
| P/B | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Tangible Book | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Cash Flow | · | · | -2.4 | · | · | · | -199.5 | · | · | · | · | |
| P / FCF | · | · | -2.4 | · | · | · | -198.9 | · | · | · | · | |
| EV / EBITDA | · | · | · | · | 0.5 | · | · | · | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-03-31 | 2024-03-31 | 2023-03-31 | |
|---|---|---|---|
| Przychody | $0 | $0 | $0 |
| Zysk netto | $-11M | $-15M | $-2M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.